LINC02348

Across TCGA pan-cancer cohorts, LINC02348 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of LINC02348’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC02348 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC02348 is over-expressed in tumor, although a few such as CHOL show the opposite, repressed pattern.

KIRC, BRCA, and LUSC are the cancer types where LINC02348 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02348 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+4.114	<.001	12	view →
BRCA	All	III,IV	+0.577	<.001	6	view →
LUSC	All	All	+0.264	<.001	6	view →
KIRP	All	II,III,IV	+0.443	.016	4	view →
COAD	Female	All	+0.095	.010	4	view →
CHOL	All	All	−1.134	.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

LINC02348–KIRC

Open the KIRC breakdown →